DAVID L CUNNINGHAM MD NPI 1891891594

NPI Details

David L Cunningham, MD is an urology in Ocala, FL. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. David L Cunningham, MD NPI is 1891891594. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

1901 SE 18TH AVE
BLDG. 300
OCALA, FL
ZIP 34471-215
Phone: (352) 351-1313
Fax: (352) 351-1927

The NPI 1891891594 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
• Injection, degarelix, 1 mg (HCPCS:J9155)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Bcg live intravesical instillation, 1 mg (HCPCS:J9030)
• Automated urinalysis test (HCPCS:81003)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml (HCPCS:A9579)
• Simple timed assessment of bladder emptying (HCPCS:51736)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• X-ray of abdomen, 1 view (HCPCS:74018)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Instillation of anti-cancer drug into bladder (HCPCS:51720)
• Injection, garamycin, gentamicin, up to 80 mg (HCPCS:J1580)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Simple insertion of temporary bladder tube (HCPCS:51702)
• Mri scan of pelvis before and after contrast (HCPCS:72197)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Ct scan of abdomen and pelvis before and after contrast (HCPCS:74178)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm (HCPCS:52235)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 9/16/2006 and was last updated on 1/7/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.